743:
198:
72:
25:
367:
to develop its enzymes. Using this method, scientists genetically engineer genes, then screen the enzymes produced to see if it creates the properties needed for a specific reaction. Their protein engineering platform, called CodeEvolver, uses
635:
348:
758:
778:
773:
517:
590:
416:
277:
690:
662:
273:
557:
768:
396:
304:
to provide research and development for the production of new ingredients. That same year, Codexis announced a collaboration with
763:
37:
611:
521:
714:
499:
474:
45:
41:
582:
332:
335:
announced a collaboration with
Codexis to research and create gene therapies for rare diseases, including
244:
is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.
336:
317:
175:
321:
538:
449:
154:
182:
171:
201:
8:
114:
742:
715:"Patenting Considerations for Artificial Intelligence in Biotech and Synthetic Biology"
364:
122:
104:
100:
377:
373:
369:
253:
325:
301:
285:
126:
82:
636:"Codexis, Molecular Assemblies Ink Enzyme Engineering Collaboration Agreement"
417:"Codexis, Molecular Assemblies Ink Enzyme Engineering Collaboration Agreement"
752:
352:
90:
118:
691:"Xconomy: Codexis Morphs From Big Science Project Into $ 100M Business"
663:"Xconomy: Codexis Morphs From Big Science Project Into $ 100M Business"
34:
may have been created or edited in return for undisclosed payments
289:
281:
261:
612:"Codexis and Takeda partner on gene therapies for rare diseases"
305:
257:
96:
71:
256:
and was incorporated in 2002. It went public in April 2010 on
558:"Tate & Lyle announce multiyear partnership with Codexis"
24:
736:
328:. The enzyme was in-licensed by Nestle Health Sciences.
284:. It then won a second time in 2010 for its work with
230:
40:. It may require cleanup to comply with Knowledge's
539:"Greener approach to Januvia cuts costs, ups yield"
280:(EPA) in 2006 for its work on a building block of
750:
347:In June 2020, they announced a partnership with
300:In 2017, the company entered a partnership with
555:
372:and high-throughput experimentation to learn
759:Biotechnology companies of the United States
308:to provide enzymes for metabolic disorders.
274:Presidential Green Chemistry Challenge Award
779:Companies based in Redwood City, California
774:Biotechnology companies established in 2002
545:. 17 June 2010 – via www.reuters.com.
450:"Engineering the future of biotherapeutics"
264:'s MolecularBreeding technology portfolio.
741:
316:In 2017, Codexis developed a recombinant
324:(PAH) enzyme for people who suffer from
751:
580:
684:
682:
583:"BASF readies a medical food product"
320:(PAL) enzyme, to act as a substitute
688:
660:
533:
531:
447:
443:
441:
439:
437:
278:U.S. Environmental Protection Agency
18:
16:American protein engineering company
475:"Codexis IPO blossoms on Earth Day"
13:
679:
500:"License Agreement - Maxygen, Inc"
311:
14:
790:
769:2002 establishments in California
728:
616:www.pharmaceutical-technology.com
528:
472:
434:
267:
197:
196:
70:
23:
707:
689:says, Jerry Jeff (2010-10-27).
661:says, Jerry Jeff (2010-10-27).
654:
628:
604:
593:from the original on 2019-08-04
587:Chemical & Engineering News
342:
764:Companies listed on the Nasdaq
574:
549:
510:
492:
466:
448:Hyde, Embriette (2019-09-04).
409:
389:
1:
383:
376:changes and their impacts on
358:
36:, a violation of Knowledge's
518:"Codexis, Inc.:News Release"
295:
288:on the active ingredient in
7:
581:Mullin, Rick (2017-11-13).
337:lysosomal storage disorders
318:phenylalanine ammonia-lyase
260:, and in October, acquired
138:; 22 years ago
10:
795:
247:
322:phenylalanine hydroxylase
225:
215:
192:
161:
150:
132:
110:
88:
78:
69:
351:to engineer enzymes for
155:Redwood City, California
221:165 (as of April 2020)
170:Stephen Dilly, Ph.D. (
105:Russell 2000 Component
333:Takeda Pharmaceutical
46:neutral point of view
349:Molecular Assemblies
252:Codexis is based in
556:foodnavigator.com.
217:Number of employees
115:Protein engineering
66:
397:"Codexis Overview"
365:directed evolution
123:industrial enzymes
64:
562:foodnavigator.com
239:
238:
211:
62:
61:
786:
745:
740:
739:
737:Official website
723:
722:
711:
705:
704:
702:
701:
686:
677:
676:
674:
673:
658:
652:
651:
649:
647:
632:
626:
625:
623:
622:
608:
602:
601:
599:
598:
578:
572:
571:
569:
568:
553:
547:
546:
535:
526:
525:
524:on 10 July 2012.
520:. Archived from
514:
508:
507:
496:
490:
489:
487:
485:
470:
464:
463:
461:
460:
445:
432:
431:
429:
428:
413:
407:
406:
404:
403:
393:
378:protein function
374:protein sequence
370:machine learning
272:Codexis won the
254:Redwood City, CA
235:
232:
205:
200:
199:
146:
144:
139:
74:
67:
63:
57:
54:
42:content policies
27:
19:
794:
793:
789:
788:
787:
785:
784:
783:
749:
748:
735:
734:
731:
726:
713:
712:
708:
699:
697:
687:
680:
671:
669:
659:
655:
645:
643:
634:
633:
629:
620:
618:
610:
609:
605:
596:
594:
579:
575:
566:
564:
554:
550:
537:
536:
529:
516:
515:
511:
498:
497:
493:
483:
481:
471:
467:
458:
456:
446:
435:
426:
424:
415:
414:
410:
401:
399:
395:
394:
390:
386:
361:
345:
326:phenylketonuria
314:
312:Biotherapeutics
302:Tate & Lyle
298:
286:Merck & Co.
270:
250:
229:
218:
188:
164:
142:
140:
137:
103:
93:
58:
52:
49:
44:, particularly
28:
17:
12:
11:
5:
792:
782:
781:
776:
771:
766:
761:
747:
746:
730:
729:External links
727:
725:
724:
706:
678:
653:
627:
603:
573:
548:
527:
509:
491:
473:Gelsi, Steve.
465:
433:
423:. 23 June 2020
408:
387:
385:
382:
360:
357:
344:
341:
313:
310:
297:
294:
269:
268:Pharmaceutical
266:
249:
246:
237:
236:
227:
223:
222:
219:
216:
213:
212:
194:
190:
189:
187:
186:
179:
167:
165:
162:
159:
158:
152:
148:
147:
134:
130:
129:
127:fine chemicals
112:
108:
107:
94:
89:
86:
85:
80:
76:
75:
60:
59:
31:
29:
22:
15:
9:
6:
4:
3:
2:
791:
780:
777:
775:
772:
770:
767:
765:
762:
760:
757:
756:
754:
744:
738:
733:
732:
720:
716:
710:
696:
692:
685:
683:
668:
664:
657:
641:
637:
631:
617:
613:
607:
592:
588:
584:
577:
563:
559:
552:
544:
540:
534:
532:
523:
519:
513:
505:
501:
495:
480:
476:
469:
455:
451:
444:
442:
440:
438:
422:
418:
412:
398:
392:
388:
381:
379:
375:
371:
366:
363:Codexis uses
356:
354:
353:DNA synthesis
350:
340:
338:
334:
329:
327:
323:
319:
309:
307:
303:
293:
291:
287:
283:
279:
275:
265:
263:
259:
255:
245:
243:
242:Codexis, Inc.
234:
228:
224:
220:
214:
209:
204:68.5 million
203:
195:
191:
184:
181:Ross Taylor (
180:
177:
173:
169:
168:
166:
160:
156:
153:
149:
135:
131:
128:
124:
120:
116:
113:
109:
106:
102:
98:
95:
92:
87:
84:
81:
77:
73:
68:
65:Codexis, Inc.
56:
47:
43:
39:
35:
32:This article
30:
26:
21:
20:
718:
709:
698:. Retrieved
694:
670:. Retrieved
666:
656:
644:. Retrieved
642:. 2020-06-23
639:
630:
619:. Retrieved
615:
606:
595:. Retrieved
586:
576:
565:. Retrieved
561:
551:
542:
522:the original
512:
503:
494:
482:. Retrieved
478:
468:
457:. Retrieved
453:
425:. Retrieved
420:
411:
400:. Retrieved
391:
362:
346:
343:Life science
330:
315:
299:
271:
251:
241:
240:
207:
151:Headquarters
119:biocatalysis
79:Company type
50:
38:terms of use
33:
504:www.sec.gov
479:MarketWatch
53:August 2021
753:Categories
700:2021-06-02
672:2021-05-24
621:2021-06-18
597:2021-05-27
567:2021-05-27
459:2021-03-12
454:SynBioBeta
427:2021-03-12
402:2011-04-03
384:References
359:Technology
163:Key people
640:Genomeweb
421:GenomeWeb
331:In 2020,
296:Nutrition
276:from the
176:president
91:Traded as
719:JD Supra
591:Archived
111:Industry
695:Xconomy
667:Xconomy
646:24 June
543:Reuters
484:10 June
290:Januvia
282:Lipitor
262:Maxygen
248:History
231:codexis
226:Website
208:FY 2019
193:Revenue
141: (
133:Founded
99::
306:Nestle
258:NASDAQ
157:, U.S.
97:Nasdaq
83:Public
648:2021
486:2021
233:.com
202:US$
174:and
143:2002
136:2002
101:CDXS
183:CFO
172:CEO
48:.
755::
717:.
693:.
681:^
665:.
638:.
614:.
589:.
585:.
560:.
541:.
530:^
502:.
477:.
452:.
436:^
419:.
380:.
355:.
339:.
292:.
125:,
121:,
117:,
721:.
703:.
675:.
650:.
624:.
600:.
570:.
506:.
488:.
462:.
430:.
405:.
210:)
206:(
185:)
178:)
145:)
55:)
51:(
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
